Product Introduction
Bioactivity


英文名: Tenapanor

描述: Tenapanor (RDX 5791) 是钠氢离子交换NHE3的有效抑制剂, 对人和大鼠NHE3的IC50分别是5和10 nM。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 50 mg/mL (43.67 mM)
H2O : < 0.1 mg/mL (insoluble)


关键字: inhibit | Sodium-hydrogen Exchanger | intestinal | Tenapanor | hyperphosphatemia | Sodium/hydrogen Exchanger | Inhibitor | orally active | Na+/H+ Exchanger (NHE) | phosphate absorption

相关产品: 4-Hydroxycinnamamide | Hm1a | Benzocaine | Dc1a | Myomodulin acetate(110570-93-9 free base) | Phenazopyridine hydrochloride | Mebeverine hydrochloride | L-Aspartic aicd sodium | Pterinotoxin-2 | Ranolazine

相关库: FDA-Approved Drug Library | Drug Repurposing Compound Library | Approved Drug Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | NO PAINS Compound Library